Quantification of nursing care in haemato-oncology
Authors:
M. Zítková 1; J. Mayer 2; Z. Král 2; P. Juřeníková 1
Authors‘ workplace:
Katedra ošetřovatelství, LF MU
1; Interní hematologická a onkologická klinika FN Brno a LF MU
2
Published in:
Transfuze Hematol. dnes,21, 2015, No. 2, p. 101-108.
Category:
Comprehensive Reports, Original Papers, Case Reports
Overview
An optimal number of nursing staff, including a corresponding representation of qualifications, is necessary for high quality nursing care. Many variables are involved in the process of quantifying nursing burden. Current activities focus on the creation of complex data related to nursing activities in the individual medical fields. In this research, we assessed objectively the nursing burden and studied the actual number of personnel involved in the care of 3 929 patients in a specialized clinic. The fundamental result of the analysis was the objective assessment of the nursing workload, including the time required for implementing and providing special and basic nursing care; the assessment of the other parameters of the nursing burden and mainly the establishment of optimal staffing in haemato-oncology. The time required for treating 1 patient in 24 hours is up to 250 min. Optimally, one bed would be covered by a nursing work-load of 1.2. The established proportional representation of basic and specialized nursing care of 10.7%: 89.3% can be used to determine the adequate qualification representation of the nursing staff. Although the presented data reflect the specific situation of the given workplace, it is also possible to apply them to other workplaces with the same medical specialization.
Key words:
nursing, haemato-oncology, nursing burden, quality of care, qualification
Sources
1. Zákon č. 96/2004 Sb., o podmínkách získávání a uznávání způsobilosti k výkonu nelékařských zdravotnických povolání a k výkonu činností souvisejících s poskytováním zdravotní péče a o změně některých souvisejících zákonů (zákon o nelékařských zdravotnických povoláních). Dostupné na www: http://www.mzcr.cz/legislativa/obsah/pracovnici-ve-zdravotnictvi_1792_11.html.
2. Vyhláška MZ ČR č. 55/2011 Sb., o činnostech zdravotnických pracovníků a jiných odborných pracovníků. Dostupné na www: http://www.mzcr.cz/legislativa/obsah/pracovnici-ve-zdravotnictvi_1792_11.html.
3. Doubek M, Folber F, Koristek Z, et al. Autologous hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: still not out of fashion. Ann Hematol 2009; 88(9): 881–887.
4. Doubek M, Palasek I, Pospisil Z, et al. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB or MLL gene translocations. Frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression. Exp Hematol 2009; 37: 659–672.
5. Krejci M, Brychtova Y, Doubek M, et al. Long-term results of allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin. Neoplasma 2011; 58(5): 406–414.
6. Červinek L, Černá O, Čaniga M, et al. Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice. Int J Hematol 2012; 96(5): 594–599.
7. Panovská A, Smolej L, Lysák D, et al. The outcome of chronic lymphocytic leukemia patients who relapsed after Fludarabine, Cyclophosphamide, and Rituximab. Eur J Haematol 2013; 90(6): 479–485.
8. Krejci M, Doubek M, Dusek J, et al. Combination of fludarabine, amsacrine and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia Ann Hematol 2013; 92: 1397–1403.
9. Racil Z, Weinbergerova B, Kocmanova I, et al. Invasive aspergillosis in patients with hematological malignanciesin the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009. Int J Infect Dis 2013; 17(2): 101–109.
10. Racil Z, Toskova M, Kocmanova I, et al. Micafungin asempirical antifungal therapy in hematological patients: a retrospective, multicenter study in the Czech and Slovak Republics. Leuk Lymphoma 2013; 54(5): 1042–1047.
11. Zackova D, Klamova H, Dusek L, et al. Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials? Am J Hematol 2011; 86(3): 318–321.
12. Doubek M, Mayer J. Maintenance therapy. In: Goekbuget N (editor in chief). Recommendations of the European Working Group for Adult ALL. UNI-MED, Verlag AG, Bremen-London-Boston 2011; 84–88.
13. Guilhot J, Baccarani M, Clark RE, et al. Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet. Blood 2012; 119: 5963–5971.
14. Baccarani M, Deininger MW, Rosti G, et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood 2013; 122: 872–884.
15. Pospisilova S, Gonzalez D, Malcikova J, et al. ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia. Leukemia 2012; 26: 1458–1461.
16. Cuenca-Estrella M, Bassetti M, Lass-Flörl C, Rácil Z, Richardson M, Rogers TR. Detection and investigation of invasive mould disease. J Antimicrob Chemother 2011; 66 Suppl 1: i15–24.
17. Cornelissen J, Gratwohl A, Schlenk R, et al. The European LeukemiaNet AML Working Party consensus statement on alloge-neic HSCT for patients with AML in remission: an integrated-risk adapted approach. Nat Rev Clin Oncol 2012; 9(10): 579–590.
18. Aiken L, Cimiotti J, Sloane D, Smith H, Flynn L, Neff D. Effects of nurse staffing and nurse education on patient deaths in hospitals with different nurse work environments. Medical Care 2011;49(12): 1047–1053.
19. Rafferty AM, Clarke SP, Coles J, et al. Outcomes of variation in hospital nurse staffing in English hospitals: Cross-sectional analysis of survey data and discharge records. Int J Nurs Studies 2007; 44(2): 175–182.
20. Pečenková J, Strnad L, Milka D. Pracovní zátěž sester z jejich pohledu. Ošetřovatelství -Teorie a praxe moderního ošetřovatelství 1999; 1(1): 12–14.
21. Machálková L, Mikšová Z, Mazalová L, Šamaj M. Hodnocení tělesných charakteristik a fyzické zátěže všeobecných sester. Česká antropologie 2012; 62(1): 24–29.
22. Pochylá K, Pochylý O. Metoda pro stanovení počtu a kvalifikačního zastoupení ošetřovatelského personálu na standardních ošetřovatelských jednotkách pro dospělé oborů interních, chirurgických, gynekologie a porodnictví, ošetřovatelských a pobytových lůžkách, jako východisko pro vytvoření standardu personálního vybavení daného pracoviště. 1.vyd. Praha, Galén, 2008; 6–15.
23. Myny D, Bacquer D, Van Hecke A, Beeckman D, Verhaeghe S, Van Goubergen D. Validation of standard times and influencing factors during the development of the Workload Indicator for Nursing. J Adv Nurs 2014; 70(3): 674–686.
24. Beswick S, Hill P, Anderson MA. Comparison of nurse workload approaches. J Nurs Manag 2010; 18(5): 592–598.
25. Patterson J. The effects of nurse to patient ratios. Nurs Times 2011; 107(2): 22–25.
26. Behar M, Heijden B, Camerino D, et al. Violence risks in nursing - results from the European ‘NEXT’ Study. Occupat Med 2008; 58(2): 107–114.
27. Centra vysoce specializované hematologické péče v ČR. Věstník MZ ČR, č.3/ 2014; publikováno elektronicky 29. května 2014. Dostupné na www: http://www.mzcr.cz/Legislativa/dokumenty/vestnik-c3/2014_9135_3040_11.html.
28. Vyhláška MZ ČR č. 99/2012 Sb., o požadavcích na minimální personální zabezpečení zdravotnických služeb. Dostupné na www: http://www.krvysocina.cz/VismoOnline_ActionScripts/File.ashx?id_org=450008&id_dokumenty=4042995.
29. Kelly D, Kutney-Lee A, Mchugh M, Sloane D, Aiken L. Impact of critical care nursing on 30-day mortality of mechanically ventilated older adults. Crit Care Med 2014; 42(5): 1089–1095.
31. Blegen MA, Goode CJ, Park SH, Vaughn T, Spetz J. Baccalaureate education in nursing and patient outcomes. J Nurs Admin 2013; 43(2): 89–94.
32. Aiken L, Sloane D, Bruynell L, et al. Nurse staffing and education and hospital mortality in nine European countries: a retrospective observational study. Lancet 2014; 383(9931): 1824–1830.
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2015 Issue 2
Most read in this issue
- Von Willebrand disease
- Advancements in the treatment of adult acute lymphoblastic leukaemia
- Evaluation of bone marrow therapeutic response in patients with high risk myelodysplastic syndrome
- Monoclonal antibodies in the treatment of multiple myeloma